Antifungal Drugs Market to 2027 – Global Analysis and Forecasts by 2027
                                                        Antifungal Drugs Market
Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal Infection); Drug Type 
(Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, Dermatophytosis, 
Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others), and Geography
Antifungal Drugs Market
The global Antifungal Drugs market by infection type 
segments was led by superficial fungal infection. In 2018, 
the superficial fungal infection segment held a largest 
market share of 62.1% of the Antifungal Drugs market, by 
infection type. Also, the superficial fungal infection 
segment is expected to be the fastest growing segments 
of the market in 2027 owing to change in the 
environmental condition across the globe which is 
expected to become the major factor for the growth of 
the Antifungal Drugs market.
Antifungal Drugs Market
Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the 
forecast period. Asia Pacific is recognized as a developing market for the pharmaceutical. The growth is driven by that 
countries such as China, and India which are engaged in conducting several studies.
Market Insights
Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections
The incidence of fungal infections due to numerous diseases has increased over the last few decades. Furthermore, 
bloodstream infection incidence is bimodal, with adult people and premature babies having the maximum risk. Cancer 
treatment using chemotherapy and radiation causes various changes in the body as they destruct cancer cells. Among the 
significant difference, one is that this treatment weakens the immune system that increases the chances of getting a fungal 
infection.
Antifungal Drugs Market
Growing Pharmaceutical Industry in Developing Regions
The developing nations are incredibly diverse, and the diseases and health care problems they face are somewhat variable. 
Thus, the solutions are different and must be made to fit local circumstances. Emerging nations represent an excellent 
opportunity for the pharmaceutical industry. The emerging markets are expected to be the crucial factor for offering better 
and lucrative growth opportunities for the market players to expand their business and geographic reach.
Antifungal Drugs Market
Several factors contribute to the fast growth of pharma emerging markets. The first factor is the patent cliff touching several 
registered drugs used in the market for several years. Next is the inclination towards the use of generic drugs in established and 
emerging countries, and the growing availability of biosimilar drugs. The next factor is the change in disease patterns in developing 
countries. Finally, the difference between manufacturing costs and charges for pharma growth.
Infection Type Insights
The global Antifungal Drugs market by infection type segments was led by superficial fungal infection. In 2018, the superficial fungal 
infection segment held a largest market share of 62.1% of the Antifungal Drugs market, by infection type. Also, the superficial fungal 
infection segment is expected to be the fastest growing segments of the market in 2027 owing to change in the environmental 
condition across the globe which is expected to become the major factor for the growth of the Antifungal Drugs market.
SEGMENTATION
Global Antifungal Drugs Market – By Infection Type
              Superficial Fungal Infection
             Systemic Fungal Infection
Global Antifungal Drugs Market – By Drug Type
                Echinocandins
               Azoles
               Polyenes
               Allylamines
       
Global Antifungal Drugs Market – By Therapeutic Indication
Aspergillosis  
Dermatophytosis
Candidiasis
Others
Global Antifungal Drugs Market – By Dosage Form
Drugs
Ointment
Powder
Others
 Company Profiles
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Merck And Co., Inc.
Scynexis Inc.
Novartis International AG
Antifungal Drugs Market to 2027 - Global Analysis and Forecasts By Infection Type (Superficial Fungal Infection, Systemic Fungal 
Infection); Drug Type (Echinocandins, Azoles, Polyenes, Allylamines, Others); Therapeutic Indication (Aspergillosis, 
Dermatophytosis, Candidiasis, Others); Dosage form (Drugs, Ointment, Powder, Others), and Geography
Thank You
Email :[email protected]
Phone : +1-646-491-9876